A prescription medication used for medical weight loss
I lost 71 pounds on Retatrutide over 11 months
As semaglutide and tirzepatide seek to expand their approved indications, e.g., potentially adding heart failure, chronic kidney disease or MASH, following several successful phase 3 trial readouts in 2023 and 2024, more pathways open up to Medicare reimbursement of AOMs within existing rules
According to Lilly, the manufacturer of Zepbound, someone with a commercial drug insurance plan that covers Zepbound may pay as low as $25 for a one- or three-month supply of Zepbound
Stay consistent with your shipments to ensure you always have a fresh supply
The crucial nuance is the oral pivot: Beyond injectables like tirzepatide, Lillys orforglipronan oral GLP1 in developmentcould be an equally important volume driver